Infinitus Replaces Traditional Pharma Hubs with AI-Human Hybrid Model

The shift arrives as specialty therapies grow increasingly complex, often stalling at the administrative level. Manufacturers currently grapple with slow, manual processes that lead to high patient drop-off rates before treatment even begins. Infinitus addresses this by integrating AI directly into the patient journey rather than layering it over fragmented, existing infrastructure. During recent testing, the system managed a 144% surge in patient volume without requiring a single additional hire, demonstrating that digital scaling can absorb peak demand cycles.

Ankit Jain, CEO and co-founder of Infinitus, emphasized that speed is only valuable if it remains trustworthy. The platform uses a smart hand-off system: AI agents manage intake, benefit verification, and 24/7 adherence inquiries, but automatically route any ambiguous or clinically sensitive cases to certified human staff. This approach has already gained traction among industry leaders, with a major pharmaceutical brand recently selecting the platform to oversee its end-to-end patient support program. By utilizing real-time analytics through the company's Lens tool, manufacturers can now access daily insights into patient interactions, replacing the traditional monthly reporting cycle that has long hindered rapid decision-making in the specialty pharmacy space.